Beyond Glycemic Control: SGLT2 Inhibitors as Modulators of Post-Infarction Myocardial Remodeling. CDF [Internet]. 2024 Nov. 20 [cited 2026 Sep. 27];53(03):8367-76. Available from: https://cuestionesdefisioterapia.com/index.php/es/article/view/4298